Showing 1-2 of 2 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| RETAIN-T1D: Oral GLP-1 Extension of Tirzepatide for T1D | Dasman Diabetes Institute | Ebaa Alozairi | Improving Lives | 01-December-2026 to 30-November-2029 | $639.500,00 |
| Treatment of the disease of obesity in patients with type 1 diabetes with tirzepatide | Dasman Diabetes Institute | Ebaa Alozairi | Improving Lives | 01-March-2025 to 29-February-2028 | $649.990,00 |